Skip to content

Tintelizer TPA

by Biopool AB

510(k) K934314

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 5 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 5 Oct 2026. What this means

Regulatory status

as of registry sync 5 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK934314 Date23 Feb 1994ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 5 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
Tintelizer(R) Tpa
510(k) Number
FDA Product Code
GGP
Device Class
Class II
Regulation
21 CFR Part 864.7290
Advisory Committee
Hematology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Tintelizer TPA is a Test, Qualitative and Quantitative Factor Deficiency device, classified under the Factor VIII and Factor IX Coagulation Factor Concentrate category. It is designed for the qualitative and quantitative analysis of coagulation factors, specifically Tissue Plasminogen Activator (TPA) levels, to assist in the diagnosis and monitoring of bleeding disorders. This in vitro diagnostic device provides measurable results to evaluate coagulation factor deficiencies, aiding hematologists in patient management.

The Tintelizer TPA is supplied as a qualitative and quantitative test system for laboratory use, intended for single-use only. It is regulated under FDA 510(k) clearance (K934314) and falls under Device Class II (864.7290). The device requires proper storage as specified in accompanying documentation, ensuring stability and accuracy of results. It is intended for use in hematology laboratories and adheres to standard in vitro diagnostic (IVD) safety and sterility protocols.

Other devices from Biopool AB

See all devices from Biopool AB →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Tintelizer TPA used for?

    The Tintelizer TPA is designed for qualitative and quantitative analysis of coagulation factors, specifically Tissue Plasminogen Activator (TPA) levels. It helps hematologists diagnose and monitor bleeding disorders by providing measurable results to evaluate factor deficiencies in patients.

  • How is the Tintelizer TPA supplied and intended for use?

    The Tintelizer TPA is supplied as a test system for laboratory use only and is intended for single-use applications. It is classified under coagulation factor concentrates and adheres to standard in vitro diagnostic (IVD) safety and sterility protocols, ensuring reliable performance in hematology labs.

  • Is the Tintelizer TPA sterile and how should it be stored?

    The Tintelizer TPA follows standard IVD sterility protocols, ensuring it is sterile for single-use. Proper storage instructions are provided in the accompanying documentation to maintain stability and accuracy of results. Always refer to the included guidelines for specific storage conditions.

  • What regulatory clearance does the Tintelizer TPA have?

    The Tintelizer TPA holds FDA 510(k) clearance under the reference number K934314, classified as a Device Class II (864.7290). This clearance confirms its substantial equivalence to a predicate device and ensures compliance with regulatory standards for coagulation factor testing.

  • Can the Tintelizer TPA be reused, and what are its key specifications?

    The Tintelizer TPA is explicitly designed for single-use only, ensuring accuracy and safety. Its specifications include classification under coagulation factor concentrates (Factor VIII and Factor IX) and adherence to FDA 510(k) requirements, with no reuse permitted to maintain diagnostic reliability.